News

News stories

Electric signals

Crucible Therapeutics appoints new Chief Executive Officer

Crucible Therapeutics, a University of Sheffield spinout developing novel therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, has announced the appointment of Dr Cliff Holloway as its Chief Executive Officer.
Sheffield Business Awards 2025 winners
Sheffield Business Awards 2025 winners

Triple triumph: Sheffield spinouts shine at 2025 Business Awards

Two spinout companies from the University's School of Electrical and Electronic Engineering achieved a triple triumph at this year's Sheffield Business awards, collectively taking home three awards.
Researcher working in AMRC facility

Leading investors back Northern Gritstone with new £50 million fundraise

Northern Gritstone has announced its latest fundraise of £50 million from leading institutional investors bringing its total permanent capital to £362 million.

Sheffield city centre at night time

University Spinouts: The Sheffield Difference

Sheffield is creating a strong future for University spinouts. With our growing investor network, improving infrastructure and rich talent pool, we are laying the foundations for the next generation of research-driven innovators to thrive.
Group of people talking at an event

Northern universities launch spinout mentor network to empower entrepreneurs

The universities of Sheffield, Leeds, and Manchester are proud to announce the launch of the Northern Triangle Mentor Network, a dynamic initiative designed to propel commercialisation opportunities and empower early-stage spinouts.
Medical illustration of a brain with stroke symptoms

New company Midland Pharmaceuticals launched to develop therapeutics for stroke and spinal cord injury

Researchers from the University of Sheffield and the University of Birmingham have joined forces with NLC Health Ventures to co-found a company developing new treatments for spinal cord injuries and stroke.
DNA Molecule

Sheffield spinout company grows to lead on next generation biomedicines and bioprocesses

SynGenSys, a fast-growing biotechnology company spun out of the University of Sheffield, has announced the appointment of Dr. Andy Racher as its Commercial Operations Director.